Loading...
Please wait, while we are loading the content...
A short update on new approaches to celiac disease.
| Content Provider | Europe PMC |
|---|---|
| Author | Al Ibrahmi, Btihaj Bour, Abdellatif |
| Copyright Year | 2022 |
| Abstract | Celiac disease is an autoimmune enteropathy of the small intestine, related to gluten intolerance occurring in genetically predisposed patients. Currently, the only available treatment is a lifelong gluten-free diet. However, the total avoidance of gluten is difficult and poses a challenge to patients, nutritionists and treating physicians. For this reason, scientists have developed in recent years new therapeutic approaches complementary to dietary treatment, such as modification of gluten to make gliadin non-toxic, reduction of the inflammatory response with elafin and Lactococcus Lactis, degradation of gluten by endoproteolytic enzymes, and correction of nutritional deficiencies by adding pseudo-cereals to the diet of celiac patients. This literature review focuses on the different treatment strategies for celiac disease previously studied and summarizes the latest advances in this field. (www.actabiomedica.it) |
| ISSN | 03924203 |
| Journal | Acta Bio Medica : Atenei Parmensis |
| Volume Number | 93 |
| PubMed Central reference number | PMC9828896 |
| Issue Number | 6 |
| PubMed reference number | 36533746 |
| e-ISSN | 25316745 |
| DOI | 10.23750/abm.v93i6.13673 |
| Language | English |
| Publisher | Mattioli 1885 |
| Publisher Date | 2022-12-16 |
| Publisher Place | Italy |
| Access Restriction | Open |
| Rights License | This work is licensed under a Creative Commons Attribution 4.0 International License Copyright: © 2022 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA |
| Subject Keyword | Celiac Disease Gluten-free diet Elafin Endoproteolytic enzyme Pseudocereals |
| Content Type | Text |
| Resource Type | Article |
| Subject | Medicine |